Allergies Formulary

Size: px
Start display at page:

Download "Allergies Formulary"

Transcription

1 Self-care should be encouraged as. Self Care The self care forum states: Empowering people with the confidence information to look after themselves when they can, visit the GP when they need to, gives people greater control of their own health encourages healthy behaviours that help prevent ill health in the long-term. People can often take care of themselves when they have common symptoms such as sore throats, coughs etc, for example by using over-the-counter medicines. In addition, this will potentially help to reduce pressure on the NHS resources allowing re-direction to areas of greatest need. NOTE: Caution should be exercised when encouraging self-care for patients to ensure that patinet needs can be encompassed within the over the counter sales licensing of the medicine required. For further information resources see the self care forum website. For a list of suggested self care medications to treat hayfever symptoms please see Appendix Two Formulary Key BNF Statement: Although drowsiness is rare, nevertheless patients should be advised that it can occur may affect performance of skilled tasks (eg driving); excess alcohol should be avoided. Drug Formulations Dose Notes First Line CETIRIZINE T: 10mg 10mg daily. Available to purchase over the counter - self care should be encouraged LORATADINE CHLORPHENAMINE L: 5mg/5ml Child mg twice daily. Child mg twice daily. T: 10mg Adult & children over 12 10mg daily L: 5mg/5ml Child: 2-12 Body weight under 30kg 5mg once daily Child: 2-12 Body weight over 30kg 10mg once daily T: 4mg Allergies Formulary Formulary prepared based on information found in the BNF (current version at time of formulary issue) individual drug Summary of Product Characteristics. This formulary should be used in conjunction with national guidelines. Management of Allergic Rhinitis - see CKS Guidelines Management of Allergic Conjunctivitis - Seasonal or Perennial - see CKS Guidelines British Society for Allergy & Clinical Immunology (BSACI) primary Care Guidelines- see for further information. One of the BSACI's main activities is the formulation of National Guidelines for use by allergy specialists. NICE has accredited the process used by the BSACI to produce its patient management guidelines. Accreditation is valid from 2010 until st line formulary choice Alternative formulary choice 2nd line formulary choice Shared Care (TAG Amber) Antihistamines Non - sedating Antihistamines Sedating Antihistamine Children aged 6-12 : ½ tablet 4 to 6 hourly. Maximum daily dose: 3 tablets (12mg) in any 24 hours SPC caution: reduce dose in renal impairment Available to purchase over the counter - self care should be encouraged Available to purchase over the counter - self care should be encouraged Allergies Formulary NEL CSU 1 Version: 4.0 Issued: May 2016 Review: May 2017

2 ADRENALINE (EPINEPHRINE) Emerade First Choice - Mast SODIUM Cell Stabiliser CROMOGLICATE Second Choice - OLOPATADINE (Opatanol ) L: 2mg/5ml Adult children over 12 4mg 4-6 hrly (max: 24mg/24hrs) Elderly : maximum 12mg / 24 hours. Not recommended under 1yr Child: 1-2 1mg twice daily 2-6 1mg every 4-6 hours - (max 6mg daily) mg every 4-6 hours - (max 12mg daily) IM Inj 150 microgram Patients 15-30kg in weight One injection when anaphylaxis symptoms present. Another dose 5-15 minutes later if deterioration or no clinical improvement. IM Inj 300 microgram Patients greater than 30kg One injection when anaphylaxis symptoms present. Another dose 5-15 minutes later if deterioration or no clinical improvement. IM Inj Drops: Drops: 500 microgram Allergic Emergencies ADULT CHILD over 12 at risk of severe anaphylaxis, 500 micrograms repeated after 5 15 minutes as necessary. 1mg/ml Adult Child over 3 : Apply twice daily. Adult: one spray each nostril twice daily The elderly are more likely to experience neurological anticholinergic effects. Contraindicated with MAOIs Emergency use for anaphylaxis - Emerade is currently recommended as the cost effective choice for new patients. It has approximately double the use by date compared to other brs. Existing patients should be prescribed the br they have been trained to use. MHRA 2014 See link below. Adrenaline Autoinjector Advice for healthcare professionals: Ensure that people with allergies their carers have been trained to use the particular auto-injector that they have been prescribed. Injection technique varies between injectors. Encourage people with allergies their carers to obtain practise using a trainer device (available for free from the manufacturers websites). Advice to give to people with allergies their carers: Carry TWO adrenaline auto-injectors at all times. This is particularly important for people who also have allergic asthma as they are at increased risk of a severe anaphylactic reaction. MHRA Drug Safety Update : Adrenaline Autoinjectors - Advice for Patients Healthcare Professionals. Available to purchase over the counter - self care should be encouraged Ensure generic prescribing of 13.5ml pack size as much cheaper Contains Benzalkonium chloride, soft contact lenses should not be worn during treatment period. Seasonal allergic conjunctivitis Max duration of treatment 4 months. Side effects are uncommon. Has dual action as both a mast cell stabiliser antihistamine. Contains Benzalkonium chloride, soft contact lenses should not be worn during treatment period. Otrivine-Antistin Rapid acting intermittent use antihistamine eye drop for use in patients over 12 can be purchased over the counter Drugs used in Nasal Allergies Antihistamines AZELASTINE (Rhinolast ) Spray: Other Anti-inflammatory preparations for the Eye 2% 140micrograms/ spray Apply one or two drops in each eye 4 times daily. Perennial seasonal allergic rhinitis. Useful for controlling breakthrough symptoms in allergic rhinitis Child: 6 over - one spray each nostril twice daily Not recommended for children under 6 Allergies Formulary NEL CSU 2 Version: 4.0 Issued: May 2016 Review: May 2017

3 Corticosteroids First Choice- Adults BECLOMETASONE DIPROPIONATE First Choice- Children MOMETASONE FUROATE Spray: Spray: Aqueous nasal spray 50 micrograms/spray 50 microgram per dose pump nasal spray, 140-dose unit Adult & Child over micrograms (2 sprays) each nostril twice daily. Max total 400 micrograms (8 sprays) daily. When symptoms controlled, dose reduced to (1 spray) into each nostril twice daily. Beconase currently cheaper than generic Not recommended for children under 6 Available to purchase as over the counter (OTC) but DO NOT prescribe as OTC Beconase Hay fever as this is expensive on FP10. Please prescribe 200 dose pack - currently cheaper than 180 dose. Minimum dose should be used at which effective control of symptoms is maintained. Rhinitis, Not recommended for children under 3. Child 3 11, 1 spray in each nostril once daily. The patient should continue regular use to achieve full Adults & Adolescent 12 therapeutic benefit. over: 2 sprays in each nostril once daily, increasing to 4 sprays in each nostril once daily if necessary. Reduce to 1 spray in each nostril once daily when controlled. Second Choice BUDESONIDE (Rhinocort Aqua ) Spray: Aqueous nasal spray 64 micrograms/spray Adults & Adolescent 12 over: spray 2 sprays into each nostril once daily in the morning. Alternatively - one spray in each nostril morning evening. When control achieved 1 spray each nostril daily. Available OTC for 18 over. Not recommended for children under 12. Maximum duration of use - 3 months. Minimum dose should be used at which effective control of symptoms is maintained MOMETASONE FUROATE Spray: Nasal spray 50 micrograms / spray Adults & Adolescent 12 over: spray 2 sprays into each nostril once daily, increased if necessary to max 200 micrograms (4 sprays) into each nostril once daily. When control is achieved reduce to 50 micrograms (1 spray) into each nostril once daily. Child 6 to 11 : 50 micrograms (1 spray) into each nostril once daily. Not recommended for children under 6. It may take several days of treatment to achieve maximum benefit. Duration of treatment should be restricted to the period that corresponds to allergenic exposure. Intermittent mild symptoms Intermittent or regular oral antihistamines are a good first choice. Intranasal antihistamines have a faster onset of action. Intermittent moderate to severe symptoms Intermittent or regular oral or nasal antihistamines. Treatment Options for Hay Fever Intranasal corticosteroids or decongestants ease nasal congestion. Intranasal decongestants can be used short-term to relieve congestion allow penetration of an intranasal corticosteroid. Available OTC Persistent moderate to severe symptoms Intranasal corticosteroids are the first-choice treatment. Intranasal decongestants can be used short-term to relieve congestion allow penetration of an intranasal corticosteroid. If symptoms remain uncontrolled, increase the corticosteroid dose or use a different one. If itching sneezing are troublesome, an antihistamine can be used. If non- allergic watery rhinorrhoea is the predominant symptom, try intranasal ipratropium Rinatec. If symptoms continue to be poorly controlled, consider a short course of oral corticosteroids. Allergies Formulary NEL CSU 3 Version: 4.0 Issued: May 2016 Review: May 2017

4 If eye symptoms predominate Oral antihistamines can be taken intermittently or regularly. Intraocular antihistamines are an alternative act more rapidly; they may be preferable for intermittent use. Otrivine- Antisitin can be bought over the counter. Intraocular sodium cromoglicate can also be used for prophylaxis or persistent eye symptoms. CKS Classification of allergic rhinitis: - Intermittent symptoms occur less than 4 days a week for less then 4 weeks. Persistent symptoms occur more than 4 days per week for mote then 4 weeks. Mild symptoms are not troublesome normal activities, such as sleep, sport, leisure, work school, are unaffected. Moderate symptoms are troublesome one or more of the following occur: impairment of normal activities, such as sport, leisure, work school; disturbed sleep. Allergies Formulary NEL CSU 4 Version: 4.0 Issued: May 2016 Review: May 2017

5 Appendix ONE

6

7 Intended as a reference for healthcare professionals only Not to be given to patients Information Key 1st line choice Alternative choice Not on formulary General Sale List Pharmacy Only Medicine Encouraged On Formulary Non-Formulary [GSL] GSL P-Med! Range price is up to date as per ! Dose age restrictions may apply for OTC formulations 10mg tablet 1mg/1ml liquid 10mg tablet 1mg/1ml liquid Antihistamines Non-sedating Antihistamines BNF Statement: Although drowsiness is rare, nevertheless patients should be advised that it can occur may affect performance of skilled tasks (eg driving); excess alcohol should be avoided. Cetirizine (generic) Loratadine (generic) Over The Counter Hayfever Drugs 10mg daily Child mg (half tab) twice daily 10mg daily Child mg twice daily Child mg twice Adults & children over 2 with body weight > 30kg 10mg daily Adults & children over 2 with body weight > 30kg 10mg daily Child 2-12 with body weight < 30kg 5mg once daily. 7, 14, 30, tabs [GSL] 100m [GSL] SPC caution: 60 tabs reduce dose in renal impairment 7, 14, 30, tabs [GSL] 70ml [GSL] 60 tabs 7 tablets: tablets tablets tablets ml pack tablets: tablets tablets tablets ml pack 4.49 Acrivastine 8mg capsule 8mg up to three times daily 12 Cap [GSL] 24 Cap pharmacies SPC caution: not recommended for use in the elderly in significant renal impairment 12 capsules capsules 8.49 Benadryl ) Issue date; March-2016 For further information please contact WN Prescribing Medicine Management Team Review date: March-2017

8 Antihistamines Sedating Antihistamines Chlorphenamine 4mg tablet 2mg/5ml liquid 4mg every 4-6 hours (max 24mg/24hrs) Child mg (½ tablet) every 4 to 6 hours. (max 12mg daily) Elderly: maximum 12mg / 24 hours. Not recommended <1yr Child: 1-2 1mg twice daily Child: 2-6 1mg every 4-6 hours - (max 6mg daily) Child: mg every 4-6 hours - (max 12mg daily) only The elderly are more likely to experience neurological anticholinergic effects. Contraindicated with MAOIs 30 tablets tablets 6.39 Piriton ) 150ml pack 3.36 Piriton ) Mast cell stabiliser Sodium Cromoglycate 2% eye drops Antihistamine / decongestant Anti-inflammatory preparations for the Eye Apply one or two drops in each eye 4 times daily [GSL] Contains Benzalkonium chloride, avoid with soft contact lenses 5ml pack ml pack 5.74 Opticrom allergy ) (Preservative Free preparation also available 20 Unit dose 7.99) Contraindicated with MAOIs Antazoline 0.5% ylometazoline 0.05% (Otrivine- Antistin ) eye drops Adult & Child over drops two to three times daily (Rapid acting, for intermittent use) pharmacies only Not to be used in narrow angle glaucoma Contains Benzalkonium chloride, avoid with soft contact lenses 10ml pack 4.48 Issue date; March-2016 For further information please contact WN Prescribing Medicine Management Team Review date: March-2017

9 Corticosteroids Beclometasone Fluticasone Triamcino-lone Topical decongestant 50mcg/spray aqueous nasal spray 50mcg/spray nasal spray 55mcg/spray nasal spray Adult over mcg (2 sprays) each nostril twice daily. Max total 400 mcg (8 sprays) daily Maintenance dose: (1 spray) into each nostril twice daily Adult over mcg (2 sprays) each nostril daily. Max total 200 mcg daily (2 sprays twice daily) Maintenance dose: (1 spray) into each nostril once a day Adult over mcg (2 sprays) each nostril daily. Maintenance dose: (1 spray) into each nostril once a day 100 spray [GSL] 180 spray pharmacies pharmacies only some pharmacies only Minimum dose should be used at which effective control of symptoms is maintained. Minimum dose should be used at which effective control of symptoms is maintained. Minimum dose should be used at which effective control of symptoms is maintained. 100 sprays sprays 8.49 Beconase hayfever ) 60 sprays 7.89 Pirinase Hayfever ) 30 sprays 5.17 Nasacort ) 0.1% spray nasal spray spray once in each nostril 1- [GSL] MA USE: 7 ylometazoline 0.1% drop nasal drops 0.05% drop child nasal drops Drugs used in Nasal Allergies Max use 7 days, preferably for controlling nightime nasal congestion 3 times daily Use 2-3 drops in each nostril 2-3 times daily Children 6-12 Use 1-2 drops in each nostril 1-2 times daily (Max 2 doses in 24 h) pharmacies only consecutive days (risk of rebound congestion) CHILD DROPS: MA USE: 5 consecutive days 10ml spray 2.30 Otrivine ) 10ml drops 3.36 Otrivine ) 10ml drops 3.05 Otrivine child ) Oxymetazoline 0.05% spray nasal spray 1-2 sprays into each nostril, 6-8 hourly [GSL] MA USE: 7 consecutive days (risk of rebound congestion) 10ml spray 1.00 Vicks ) Normal saline solution Saline solution 0.9% sodium chloride sprays/drops Most preparations suitable from birth (but [GSL] check product specifications) Apply several times per day as required Various preparations Issue date; March-2016 For further information please contact WN Prescribing Medicine Management Team Review date: March-2017

10 Intended for short-term use only Systemic Decongestant 60mg tablet ONE every 4-6 hours up to 4 times a day 12 tablets 3.00 Sudafed ) Pseudoephredine 30mg tablet 30mg/5ml liquid ONE to TWO every 4-6 hours (Please refer to product for MA daily dose) 10ml every 4-6 hours (Max 4 doses in 24 h) Children ml every 4-6 hours (Max 4 doses in 24 h) pharmacies only Product or combination of products sold must no contain more than 720mg of pseudoephedrine (usually 1 pack) 15 tablets tablets tablets 5.99 Brs include: Sinutab (contains paracetamol) Sudafed sinus (contains ibuprofen) 100ml pack 3.28 Sudafed ) Title Over The Counter Hayfever Drugs References Allergies Formulary Autumn/Winter 2015 Guide to OTC Boots website URL: (accessed on ) Tesco direct website URL: (accessed on ) Issue date; March-2016 For further information please contact WN Prescribing Medicine Management Team Review date: March-2017

11 Title Allergies Formulary Persons/Bodies consulted during preparation. Other relevant resources Consultation on Documents Training Implications Monitoring Audit Dissemination Approved by Authorised by Review date by whom Date of Issue Senior Medicines Management Team, NEL Norfolk Waveney Prescribing Reference Group, NICE Guidance, British Society for Allergy & Clinical Immunology (BSACI) CKS Guidelines - Management of Allergic Conjunctivitis - Seasonal or Perennial Management of Allergic Rhinitis Norfolk Waveney Prescribing Reference Group NEL CSU Medicine Management Team Relevant NHS Anglia Programme Commissioning Boards Formulary Pharmacists at Norfolk & Norwich University Hospitals Trust, Queen Elizabeth Hospital Kings Lynn NHS Trust, James Paget University Hospital Trust Norfolk & Waveney Mental Health Care Partnership Trust. Promotion to Primary Care prescribers via Medicine Management Team Evaluation maintenance managed by the NEL N&WPRG To be prepared by the NEL CSU Medicines Management Team, Approved by the N&WPRG, signed off by the PRG- added to NHS Knowledge Anglia, Disseminated to the Norfolk Waveney CCGs for adoption as a working document to advise the Primary Care Prescribers within their CCG. Norfolk Prescribing Reference Group, Drugs Therapeutics Committee see below see below Version Date Author Comment 1 17/05/2013 Draft /05/2014 Draft /06/2014 Version 2 19/06/2014 Passed at SMT To remove the nedocromil option leave sodium cromoglycate. To add Olopatadine as a second line option has Mast cell stabilisation antihistamine action can be used for children over 3 twice daily application for up to 4 months treatment. Add note to state Otrivine Antistin useful product, over 12 can be purchased OTC. Add a link to the British Society for Allergy & Clinical Immunology (BSACI). Update the links to CKS. PRG passed Sodium Cromoglycate first line, Olopatadine as second line. Addition of 999 emergency information to Adrenaline autoinjector. Link to BSACI approved. Approved by D&T for publication. Version 2.1 draft April 2015 Update of all links. Update of listed drugs from SPC information. Version 2.1 draft April 2015 remove 999 information add information re carrying of TWO autoinjectors. Version 3.0 draft May-15 Add Mometasone as generic instead of Fluticasone (Avamys br) as cost effective choice. Links to BNF NPC removed as no longer active. Version 3.0 FINAL May-15 Removed Mometasone to simplify choices.final Approved from D&T. Version 3.1 FINAL Oct-15 Ammendment - list preferred cost effective choice of Adrenaline Autoinjector as Emerade add prescribing information for all strengths150, micrograms. Version 4.0 May-16 Added - Emerade info - approximately double the expiry date of others. Self care strap line at the start. Added Mometasone for children first line. Added advice leaflet OTC product guide for professionals use.

Allergies Formulary. Self Care

Allergies Formulary. Self Care How does the guidance apply to this formulary? For full information see: NHSE Guidance to CCGs A quick reference guide for professionals is also available which contains hyperlinks to the conditions for

More information

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010

Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 Volume 4; Number 4 April 2010 PRESCRIBING GUIDANCE FOR HAY FEVER: SPRING / SUMMER 2010 PACEF Recommendations Recommended medicines remain the same as in recent years: Non-sedating antihistamines: generic

More information

Product Cost per Pack Cost per 28 days (assuming 2 sprays od) Flixonase years 50mcg in both nostrils od (increasing to max bd prn)

Product Cost per Pack Cost per 28 days (assuming 2 sprays od) Flixonase years 50mcg in both nostrils od (increasing to max bd prn) Protocol for Flixonase to Avamys Nasal Spray Switch May 2010 1. Reason Avamys contains the corticosteroid fluticasone furoate (27.5mcg/spray) and Flixonase nasal spray contains fluticasone propionate (50mcg/spray).

More information

Hayfever. Allergic reaction. Prognosis

Hayfever. Allergic reaction. Prognosis Hayfever Hay fever is a type of allergic rhinitis caused by pollen or spores. Allergic rhinitis is a condition where an allergen (something that causes an allergic reaction) makes the inside of your nose

More information

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Subject: Presented By: Submitted To: Purpose of Paper: Self-care for Self-Limiting Conditions Policy Karen Watts, Director of Quality

More information

The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1

The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1 The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium fluticasone furoate, 27.5 micrograms /actuation nasal (Avamys ) No. (544/09) GlaxoSmithKline 06 March 2009 The Scottish Medicines Consortium (SMC) has completed its assessment

More information

ARIA. At-A-Glance Pocket Reference 2007

ARIA. At-A-Glance Pocket Reference 2007 ARIA_Glance_2007_8pg:ARIA_Glance_English 9/14/07 3:10 PM Page 1 ARIA At-A-Glance Pocket Reference 2007 1 st Edition NEW ARIA UPDATE BASED ON THE ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA WORKSHOP REPORT

More information

CLINICAL POLICIES FORUM

CLINICAL POLICIES FORUM Date of Meeting: 10 September 2013 CLINICAL POLICIES FORUM For: Note: To note Edits to Allergic Rhinitis Primary Care Pathway to reflect change in treatment group over 12 year olds Changes to text within

More information

Your guide to... managing hayfever.

Your guide to... managing hayfever. Your guide to... managing hayfever www.boots.com/pharmacyteam Boots is better than ever There are now 15,000 health experts, including pharmacists, Healthcare Consultants and Healthcare Advisors in more

More information

Seasonal Allergic Rhinitis (Hay Fever)

Seasonal Allergic Rhinitis (Hay Fever) Seasonal Allergic Rhinitis (Hay Fever) Link to prescribing guidance: http://www.enhertsccg.nhs.uk/ear-nose-and-oropharynx Clinical Presentation Link to CKS NICE guidance: https://cks.nice.org.uk/allergicrhinitis

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium montelukast 10mg tablets (Singulair ) No. (185/05) Merck, Sharp & Dohme Ltd (MSD) New indication: for asthmatic patients in whom montelukast is indicated in asthma, montelukast

More information

Oral Agents. Fml Limits. Available Strengths NF NF

Oral Agents. Fml Limits. Available Strengths NF NF MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Allergy Medications LAST REVIEW: 9/12/2017 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 9/16, 5/15, 9/14

More information

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml

Oral Agents. Formulary Limits. Available Strengths. IR: 4mg ER: 12mg Syrup: 2mg/5ml MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Seasonal Allergy Medications LAST REVIEW: 9/20/2016 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 5/16, 5/15,

More information

Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine

Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine Beconase Hayfever (Beclomethasone dipropionate, 50 per actuation) Proposal To reclassify Beconase Hayfever (beclomethasone 50 g/actuation) from Restricted Medicine to Pharmacy Medicine Background to current

More information

The management of chronic urticaria in primary care for adults and children

The management of chronic urticaria in primary care for adults and children The management of chronic urticaria in primary care for adults and children September Version 2.0 This supersedes version 1.0 Review due in September 2019 Document location DOCUMENT CONTROL Copies of this

More information

Medicine Review. Medicine / Trade name Azelastine and fluticasone / Dymista Manufacturer

Medicine Review. Medicine / Trade name Azelastine and fluticasone / Dymista Manufacturer East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast East Anglia Medicines Information Service Medicine Review Medicine / Trade name Azelastine

More information

3 RESPIRATORY SYSTEM

3 RESPIRATORY SYSTEM 3 RESPIRATORY SYSTEM 3.01 ANTIASTHMATICS 3.01a BETA 2 AGONIST ASTHMA, CHRONIC BRONCHITIS & EMPHYSEMA Salbutamol Inhaler 100ug/dose [Albuterol] (Ventolin) Salbutamol Sulphate Respirator Solution 0.5% (5mg/ml),

More information

Volume 7; Number 12 July 2013

Volume 7; Number 12 July 2013 Greater East Midlands Commissioning Support Unit in association with Lincolnshire Clinical Commissioning Groups, Lincolnshire Community Health Services, United Lincolnshire Hospitals Trust and Lincolnshire

More information

Chapter 3: Respiratory System (7 th Edition)

Chapter 3: Respiratory System (7 th Edition) Chapter 3: Respiratory System (7 th Edition) The Sheffield respiratory guidelines (April 2015) have been removed from the intranet. This is because the COPD section has been superseded by the COPD treatment

More information

What is Allergic Rhinitis?

What is Allergic Rhinitis? What is Allergic Rhinitis? Hay fever is the common name for allergic rhinitis; rhino meaning of the nose and its meaning inflammatory. Thus, allergic rhinitis is defined as an inflammation of the nose

More information

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet

ODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet pteronyssinus) allergen extract sublingual tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.

More information

Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications

Triage Information: 1. Duration of HPSJ Membership 2. Age 3. Fill history of Seasonal Allergy Medications MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Seasonal Allergy Medications LAST REVIEW: 5/28/2015 THERAPEUTIC CLASS: Rheumatologic/Immunologic REVIEW HISTORY: 5/15, 9/14

More information

Allergy and inflammation

Allergy and inflammation and inflammation 1 Allergic population hyper-producers of IgE consistently increasing western societies: ~20% of general population 2 Allergic population 3 Allergic triggers 4 Allergic triggers abnormal

More information

Fluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR.

Fluticasone propionate, 50 mcg per spray. Please read this leaflet carefully before you use FLIXONASE ALLERGY & HAYFEVER 24 HOUR. FLIXONASE ALLERGY & HAYFEVER 24 HOUR Fluticasone propionate, 50 mcg per spray Consumer Medicine Information What is in this leaflet? Please read this leaflet carefully before you use FLIXONASE ALLERGY

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

Clinical Policy: Antihistamines Reference Number: CP.HNMC.18 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Clinical Policy: Antihistamines Reference Number: CP.HNMC.18 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal Clinical Policy: Reference Number: CP.HNMC.18 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

2 What you need to know before you use Beconase. Package Leaflet: Information for the user Package Leaflet: Information for the user Beconase Aqueous Nasal Spray beclometasone dipropionate 50 micrograms Read all of this leaflet carefully before you start using this medicine because it contains

More information

Newsletter June 2013

Newsletter June 2013 Newsletter June 2013 West Malling Group Practice Patient Participation Group wmgpppg@gmail.com Our Next Patient Information Evening Wednesday 7th August 6.30-8pm at West Malling Surgery We have 2 speakers

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. RAGWITEK (Short Ragweed Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage Guideline

More information

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine.

TRIPROLIDINE. Please read this leaflet and the packaging of the medicine you purchased, carefully before you start using triprolidine. TRIPROLIDINE New Zealand Consumer Medicine Information What is in this leaflet The medicine you have purchased contains triprolidine. This leaflet is intended to provide information on the active ingredient

More information

Pharmacotherapy for Allergic Rhinitis

Pharmacotherapy for Allergic Rhinitis Pharmacotherapy for Allergic Rhinitis William Reisacher, MD FACS FAAOA Assistant Professor Weill Cornell Medical College The Impact of Allergic Rhinitis Allergic rhinitis affects approximately 50 million

More information

BNF CHAPTER 3: RESPIRATORY

BNF CHAPTER 3: RESPIRATORY 3.1 BRONCHODILATORS BNF CHAPTER 3: RESPIRATORY 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated (e.g., Easi-Breathe

More information

How to spot allergies. What are allergies? What can your patients do about allergies? How allergies cause sinusitis. Module 5 Allergies

How to spot allergies. What are allergies? What can your patients do about allergies? How allergies cause sinusitis. Module 5 Allergies Module 5 Allergies What are allergies? Allergies occur when a patient s immune system has a hypersensitive response to a substance that the body comes into contact with 1a. These substances, called allergens,

More information

Re-submission. Scottish Medicines Consortium. Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd

Re-submission. Scottish Medicines Consortium. Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd Scottish Medicines Consortium Re-submission Olopatadine 1mg/ml eye drops, solution (Opatanol ) No. 59/03) Alcon Laboratories (UK) Ltd 9 December 2005 The Scottish Medicines Consortium (SMC) has completed

More information

Fluticasone furoate (Avamys): new intranasal steroid spray Steve Chaplin MSc, MRPharmS

Fluticasone furoate (Avamys): new intranasal steroid spray Steve Chaplin MSc, MRPharmS Fluticasone furoate (Avamys): new intranasal steroid spray Steve Chaplin MSc, MRPharmS KEY POINTS Avamys is a metered-dose nasal spray containing 27.5µg fluticasone furoate per dose indicated for the treatment

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium Standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate (Grazax ) No. (367/07) ALK-Abellό Ltd 6 April 2007 The Scottish

More information

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults

Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Guidance on Safe Prescribing of Melatonin for Sleep Disorders in Children, Young People and Adults Ref: PHARM-0025-v3 Status: FINAL Document type: Guidelines Guidance on Safe Prescribing of Melatonin Page

More information

Opinion 5 February 2014

Opinion 5 February 2014 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 5 February 2014 DYMISTA 137 µg/50 µg, nasal spray suspension Bottle with 23 g suspension of 25 ml or around 120 doses

More information

NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate

NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate NASONEX Aqueous Nasal Spray 0.05% Mometasone Furoate Monohydrate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NASONEX. It does not contain all

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 01/21/2015 Effective date: 02/21/2015 Therapeutic Classes reviewed: Allergen-Specific Immunotherapy

More information

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services The supply of Champix (Varenicline) Tablets 500mcg and 1mg by registered community pharmacists for smoking cessation / management of nicotine withdrawal for adults engaged with the Family Wellbeing Service

More information

Products for children from 6 to 12 will continue to be available in pharmacies where advice can be given.

Products for children from 6 to 12 will continue to be available in pharmacies where advice can be given. 28 February 2009 Dear Colleague Over-the-counter cough and cold medicines for children Issue The Commission on Human Medicines (CHM) has advised on a package of measures to improve the safe use of cough

More information

3. Respiratory System

3. Respiratory System 1 3. Respiratory System Also see Appendix 3A Guidance on Management of Also see Appendix 3B Preferred Inhaler Devices for Adults Also see Appendix 3C Preferred Inhaler Devices for Adolescents (12-18 years)

More information

Recommended management and recent advances in allergic rhinitis

Recommended management and recent advances in allergic rhinitis DRUG REVIEW n Recommended management and recent advances in allergic rhinitis Gill Schofield RSCN, MSc and Sophie Farooque MRCP Allergic rhinitis is a common and undertreated condition and is often a precursor

More information

ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12

ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12 North Hampshire CCG Asthma Prescribing Guidelines June 2015 ASTHMA PRESCRIBING GUIDELINES FOR ADULTS AND CHILDREN OVER 12 These guidelines are based on the British Thoracic Society (BTS) and Scottish Intercollegiate

More information

Middleton Chapter 42b (pages ): Allergic and Nonallergic Rhinitis Prepared by: Tammy Peng, MD

Middleton Chapter 42b (pages ): Allergic and Nonallergic Rhinitis Prepared by: Tammy Peng, MD FIT Board Review Corner November 2017 Welcome to the FIT Board Review Corner, prepared by Amar Dixit, MD, and Christin L. Deal, MD, senior and junior representatives of ACAAI's Fellows-In- Training (FITs)

More information

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device 3.1 BRONCHODILATORS 3.1.1.1 SELECTIVE BETA 2 -AGONISTS Short acting Salbutamol Terbutaline 100 micrograms/actuation aerosol inhaler 100 micrograms/actuation breath-actuated e.g. Easi-Breathe 200 micrograms/dose

More information

Package leaflet: Information for the patient. Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension

Package leaflet: Information for the patient. Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension Package leaflet: Information for the patient Dymista Nasal Spray 137 micrograms / 50 micrograms per actuation Nasal Spray, Suspension Azelastine hydrochloride/fluticasone propionate Read all of this leaflet

More information

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and

More information

OSPAP Programme MPHM13 Respiratory OTC Seminar

OSPAP Programme MPHM13 Respiratory OTC Seminar OSPAP Programme MPHM13 Respiratory OTC Seminar Slide 1 of 41 MPH14 OSPAP OTC Respiratory Learning Objectives: By the end of this session, you should be able to: Recognise signs and symptoms of common respiratory

More information

Chapter 12 Ear, Nose and Oropharynx

Chapter 12 Ear, Nose and Oropharynx Chapter 12 page number 1 Chapter 12 Ear, Nose and Oropharynx First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both

More information

Latest advances in the management of childhood allergic rhinitis

Latest advances in the management of childhood allergic rhinitis Latest advances in the management of childhood allergic rhinitis Jason Y K Chan Assistant Professor Department of Otorhinolaryngology, Head & Neck Surgery The Chinese University of Hong Kong Disclosures

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Immunotherapy Agents Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Immunotherapy Agents Prime Therapeutics will review Prior Authorization

More information

CONSULTATION DOCUMENT: ARM 83 PIRINASE HAYFEVER RELIEF FOR ADULTS 0.05% NASAL SPRAY

CONSULTATION DOCUMENT: ARM 83 PIRINASE HAYFEVER RELIEF FOR ADULTS 0.05% NASAL SPRAY Dear Sir/Madam 7th January 2013 CONSULTATION DOCUMENT: ARM 83 PIRINASE HAYFEVER RELIEF FOR ADULTS 0.05% NASAL SPRAY REQUEST TO RECLASSIFY A PRODUCT FROM P TO GSL I am writing to inform you that consultation

More information

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma

Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going

More information

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description

Ragwitek. Ragwitek (Short Ragweed Pollen Allergen Extract) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.20.05 Subject: Ragwitek Page: 1 of 5 Last Review Date: December 8, 2017 Ragwitek Description Ragwitek

More information

Can flonase cause hyperactivity

Can flonase cause hyperactivity Can flonase cause hyperactivity 12-3-2018 Learn about the potential side effects of Flonase. Flonase Side Effects. Generic. (the active ingredient contained in Flonase ) may cause some. 6-12-2017 Fluticasone

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: House dust mite allergen extract (Odactra) Reference Number: CP.PMN.111 Effective Date: 08.01.17 Last Review Date: 08.18 Line of Business: Commercial, Medicaid Revision Log See Important

More information

Disclosure. OTC Review with a Pediatric Twist. Objectives. When to Call a Doctor for Infant. When to Call a Doctor for Child

Disclosure. OTC Review with a Pediatric Twist. Objectives. When to Call a Doctor for Infant. When to Call a Doctor for Child OTC Review with a Pediatric Twist Disclosure Consultant for Johnson and Johnson Baby Jill A. Morgan, PharmD, BCPS February 2015 Objectives List situations when a child should be referred to physician.

More information

Opinion 8 January 2014

Opinion 8 January 2014 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 8 January 2014 WYSTAMM 1 mg/ml, oral solution 120 ml vial with syringe for oral administration (CIP: 34009 222 560

More information

Azelastine Nasal Spray 1 mg / 1 ml

Azelastine Nasal Spray 1 mg / 1 ml Package Leaflet: Information for the User Allergodil 0,1% nasal spray, solution Active substance: Azelastine hydrochloride Read all of this leaflet carefully because it contains important information for

More information

Atomoxetine Effective Shared Care Agreement For Attention Deficit Hyperactivity Disorder (ADHD)

Atomoxetine Effective Shared Care Agreement For Attention Deficit Hyperactivity Disorder (ADHD) Atomoxetine Effective Shared Care Agreement For Attention Deficit Hyperactivity Disorder (ADHD) Section 1: Shared Care arrangements and responsibilities Section 1.1 Agreement to transfer of prescribing

More information

An Update on Allergic Rhinitis. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

An Update on Allergic Rhinitis. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital An Update on Allergic Rhinitis Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Allergic Rhinitis Common condition with increasing prevalence

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET NEW ZEALAND DATA SHEET ALANASE Beclometasone dipropionate Aqueous Nasal Spray 50 µg & 100 µg per actuation Presentation ALANASE Aqueous Nasal Spray (50 micrograms per actuation) is an almost white opaque

More information

Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract)

Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Oralair Page: 1 of 5 Last Review Date: November 30, 2018 Oralair Description Oralair (Sweet Vernal,

More information

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women.

ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. ESCA: Denosumab for the treatment of osteoporosis in postmenopausal women. Specialist details Patient identifier Name Tel: This effective shared care agreement (ESCA) sets out details for the sharing of

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu Primary and Community Care Directorate Pharmacy Division T: 0131-244 2528 F: 0131-244 2375 E: irene.foster@scotland.gsi.gov.uk 26 March 2008 abcdefghijklmnopqrstu Directors of Pharmacy Chief Executives,

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) For ages 2 years and over. Chloramphenicol 1% eye oint. (4g) For ages 2 years and over. Allergy Loratadine

More information

RELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH

RELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH RELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH Surrey (East Surrey CCG, Guildford & Waverley CCG, North West Surrey CCG, Surrey Downs CCG & Surrey Heath) North East Hampshire & Farnham CCG, Crawley

More information

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS The November 22, 2016 Mid-Year Financial Report referred to changes to drug coverage under the Saskatchewan Drug Plan. What

More information

Application to reschedule the entries for:

Application to reschedule the entries for: Application to reschedule the entries for: (1) FLIXONASE Aqueous Nasal Spray (fluticasone propionate) (2) BECONASE Hayfever Aqueous Nasal Spray (beclomethasone dipropionate) from Restricted Medicine to

More information

Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate)

Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate) Information for the user Allergy Relief 50 microgram Nasal Spray (Fluticasone propionate) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Care at the Chemist. Formulary

Care at the Chemist. Formulary Care at the Chemist Formulary 1 Acute bacterial conjunctivitis Chloramphenicol 0.5% eye drops (10ml) Chloramphenicol 1% eye oint. (4g) Allergy Loratadine 10mg tablets (7) Sodium cromoglycate 2% eye drops

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide

PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide PACKAGE LEAFLET: INFORMATION FOR THE USER Rhinocort Aqua, 64 micrograms, Nasal Spray Budesonide Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need

More information

Clinician Responsible for Training and Review: Emergency Department Consultant

Clinician Responsible for Training and Review: Emergency Department Consultant Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This

More information

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY

GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY GENERIC MEDICINES (Non-Innovator Brand) PRESCRIBING POLICY First issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date August 2018 1.0 Promoting generic prescribing whenever

More information

Does hay fever affect your quality of life? Immunotherapy may be the answer

Does hay fever affect your quality of life? Immunotherapy may be the answer Does hay fever affect your quality of life? Immunotherapy may be the answer If your hay fever (allergic rhinitis) is causing you misery, and you re not seeing improvements in your symptoms despite trying

More information

REFERRAL GUIDELINES - SUMMARY

REFERRAL GUIDELINES - SUMMARY Clinical Immunology & Allergy Unit LEEDS TEACHING HOSPITALS NHS TRUST REFERRAL GUIDELINES - SUMMARY THESE GUIDELINES ARE DESIGNED TO ENSURE THAT PATIENTS REQUIRING SECONDARY CARE ARE SEEN EFFICIENTLY AND

More information

Comments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications

Comments. Oral Antihistamines. Chronic Drug Treatments. Oral Allergy Medications Comments: Even though OTC vasoconstrictors and antihistamines are popular, a recent article suggests that these drugs can cause rebound dilation of conjunctival vessels Chronic Drug Treatments Mast Cell

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

SAN DIEGO ALLERGY ASTHMA & IMMUNOLOGY CONSULTANTS, INC

SAN DIEGO ALLERGY ASTHMA & IMMUNOLOGY CONSULTANTS, INC SAN DIEGO ALLERGY ASTHMA & IMMUNOLOGY CONSULTANTS, INC BERNARD A. FEIGENBAUM, M.D. FACP, FAAAAI 9850 GENESEE AVE, SUITE 355 CLINICAL ASSISTANT PROFESSOR OF MEDICINE & OTOLARYNGOLOGY, NYU LA JOLLA, CA 92037

More information

PATIENT GROUP DIRECTION

PATIENT GROUP DIRECTION PATIENT GROUP DIRECTION FOR THE SUPPLY OF VARENICLINE (CHAMPIX ) TO ADULTS OVER 18 YEARS OF AGE BY COMMUNITY PHARMACISTS UNDER THE PUBLIC HEALTH SERVICE - SMOKING CESSSATION SERVICE IN NHS HIGHLAND THE

More information

12.1 DRUGS ACTING ON THE EAR

12.1 DRUGS ACTING ON THE EAR 12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,

More information

Job Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014

Job Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014 PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN FORTH VALLEY Protocol Number 445 Version 1 Date protocol prepared: June 2014 Date protocol due

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Oral Immunotherapy Agents Page 1 of 14 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Oral Immunotherapy Agents (Grastek, Oralair, Ragwitek ) Prime Therapeutics

More information

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section.

Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed Formulary Status. TA Number. Section. Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACLIDINIUM BROMIDE bronchodilators ADRENALINE/EPINEPHRINE

More information

1. NAME OF THE MEDICINAL PRODUCT. Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

1. NAME OF THE MEDICINAL PRODUCT. Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1. NAME OF THE MEDICINAL PRODUCT Vicks Sinex, 0.5 mg/ml, nasal spray solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Oxymetazoline hydrochloride 0.5 mg/ml 1 spray (50 l) contains approximately 25

More information

Seasonal Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis Seasonal Allergic Rhinoconjunctivitis Allergic rhinoconjunctivitis is a common condition. Most patients can achieve good symptom control through allergen avoidance and pharmacotherapy with non-sedating

More information

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009

Cambridgeshire Community Pharmacy Minor Ailments Service. February 2009 Cambridgeshire Community Pharmacy Minor Ailments Service February 2009 Contents 3 Constipation & Paediatric Constipation 4 Diarrhoea & Paediatric Diarrhoea 5 Indigestion & Infant Gripes/Colic/Wind 6 Hay

More information

Azelastine nasal spray: the treatment of choice for allergic rhinitis

Azelastine nasal spray: the treatment of choice for allergic rhinitis PRESS RELEASE Azelastine nasal spray: the treatment of choice for allergic rhinitis An astonishing one quarter of the planet s population suffers from allergic rhinitis, living with the aggravating symptoms

More information

1 What Flixonase is and what it is used for

1 What Flixonase is and what it is used for GSK logo Package Leaflet: Information For The User Flixonase Aqueous Nasal Spray fluticasone propionate 50 micrograms Read all of this leaflet carefully before you start using this medicine because it

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Xolair (omalizumab) Commercial HMO/PPO/CDHP HMO/PPO/CDHP: Rx

More information

Promotion of Self Care Briefing Document

Promotion of Self Care Briefing Document RCCG/GB/17/035 Promotion of Self Care Briefing Document 1. Introduction The proposal aims to promote self-care through the purchasing of medications and products from local pharmacies for the treatment

More information

Read all of this leaflet carefully before you start using this medicine.

Read all of this leaflet carefully before you start using this medicine. PACKAGE LEAFLET: INFORMATION FOR THE USER Allergo-COMOD nasal spray 20 mg/ml Nasal spray, solution Active ingredient: sodium cromoglicate (Ph. Eur.) 1 spray of 0.14 ml of Allergo-COMOD nasal spray contains

More information